2000-2017年美国ST段抬高型心肌梗死合并心源性休克与心脏骤停的结局
该研究利用美国全国住院样本(2000-2017)分析4320117例成人STEMI住院患者,中心源性休克、心脏骤停及两者并存的比例分别为5.8%、6.2%和2.7%。2017年与2000年相比,心脏骤停(aOR 1.83)、心源性休克(aOR 3.92)及两者并存(aOR 4.09)的发生率均增加。心源性休克合并心脏骤停组多器官衰竭发生率为77.2%,高于单独心源性休克组(59.7%)和单独心脏骤停组(26.3%)。该组院内死亡率较单独心源性休克(aOR 1.87)、单独心脏骤停(aOR 1.99)及两者均无(aOR 18.37)更高,且姑息治疗和放弃复苏(DNR)使用率更高。
要点
- STEMI合并心源性休克与心脏骤停者多器官衰竭发生率为77.2%,高于单独心源性休克(59.7%)和单独心脏骤停(26.3%),p<0.001。
- 心源性休克合并心脏骤停组院内死亡率较单独心源性休克(aOR 1.87,95%CI 1.83-1.91)和单独心脏骤停(aOR 1.99,95%CI 1.95-2.03)更高。
- 仅心脏骤停组冠状动脉造影率为64%,低于其他组(>70%),p<0.001。
- 2017年较2000年,心脏骤停(aOR 1.83,95%CI 1.79-1.86)、心源性休克(aOR 3.92,95%CI 3.84-4.01)及两者并存(aOR 4.09,95%CI 3.94-4.24)发生率均增加,所有p<0.001。
- 心源性休克合并心脏骤停组姑息治疗和DNR状态使用率更高,心源性休克(单独或合并心脏骤停)与更高住院费用相关。
适用人群与场景
- 成人(>18岁)STEMI住院患者,数据来自美国全国住院样本(2000-2017)。
- 按是否合并心源性休克和/或心脏骤停分为四组:心源性休克合并心脏骤停、仅心源性休克、仅心脏骤停、两者均无。
研究设计与关键结果
- 研究类型为基于美国全国住院样本(2000-2017)的回顾性分析,共纳入4320117例STEMI住院患者。
- 心源性休克、心脏骤停及两者并存的发生率分别为5.8%、6.2%和2.7%。
- 2017年与2000年比较,心脏骤停aOR 1.83(95%CI 1.79-1.86)、心源性休克aOR 3.92(95%CI 3.84-4.01)、两者并存aOR 4.09(95%CI 3.94-4.24),均p<0.001。
- 心源性休克合并心脏骤停组多器官衰竭发生率为77.2%,仅心源性休克组为59.7%,仅心脏骤停组为26.3%,p<0.001。
- 仅心脏骤停组冠状动脉造影率为64%,其他组均>70%,p<0.001。
- 院内死亡率:心源性休克合并心脏骤停组 vs 仅心源性休克组aOR 1.87(95%CI 1.83-1.91);vs 仅心脏骤停组aOR 1.99(95%CI 1.95-2.03);vs 两者均无组aOR 18.37(95%CI 18.02-18.71)。
- 心源性休克合并心脏骤停组姑息治疗和DNR状态使用率更高;心源性休克(单独或合并心脏骤停)与更高住院费用相关。
证据类型、等级与局限
- 证据类型:基于美国全国住院样本(2000-2017)的回顾性队列分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于STEMI患者,若同时合并心源性休克和心脏骤停,应意识到其多器官衰竭和院内死亡风险显著高于仅合并其中一种情况。
- 仅心脏骤停的STEMI患者冠状动脉造影率较低(64%),提示该人群接受介入评估的比例可能不足。
- 心源性休克合并心脏骤停患者姑息治疗和DNR使用率更高,临床决策时需综合评估。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: There are limited data on the outcomes of cardiogenic shock (CS) and cardiac arrest (CA) complicating ST-segment-elevation myocardial infarction (STEMI).
METHODS: Adult (>18 years) STEMI admissions were identified using the National Inpatient Sample (2000-2017) and classified as CS + CA, CS only, CA only and no CS/CA. Outcomes of interest included temporal trends, in-hospital mortality, hospitalization costs, use of do-not-resuscitate (DNR) status and palliative care referrals across the four cohorts.
RESULTS: Of the 4,320,117 STEMI admissions, CS, CA and both were noted in 5.8%, 6.2% and 2.7%, respectively. In 2017, compared to 2000, there was an increase in CA (adjusted odds ratio [aOR] 1.83 [95% confidence interval {CI} 1.79-1.86]), CS (aOR 3.92 [95% CI 3.84-4.01]) and both (aOR 4.09 [95% CI 3.94-4.24]) (all p < 0.001). The CS+CA (77.2%) cohort had higher rates of multiorgan failure than CS only (59.7%) and CA only (26.3%), p < 0.001. The CA only cohort had lower rates (64%) of coronary angiography compared to the other groups (>70%), p < 0.001. In-hospital mortality was higher in CS+CA compared to CS alone (adjusted OR 1.87 [95% CI 1.83-1.91]), CA alone (adjusted OR 1.99 [95% CI 1.95-2.03]) or neither (aOR 18.37 [95% CI 18.02-18.71]). The CS+CA cohort had higher use of palliative care and DNR status. The presence of CS, either alone or in combination with CA, was associated with higher hospitalization costs.
CONCLUSIONS: The combination of CS and CA was associated with higher rates of non-cardiac organ failure and in-hospital mortality in STEMI compared to those with either CS or CA alone.
参考来源
- Vallabhajosyula S, Dunlay SM, Prasad A, et al. Cardiogenic shock and cardiac arrest complicating ST-segment elevation myocardial infarction in the United States, 2000-2017. Resuscitation. 2020. PMID: 32755665. doi:10.1016/j.resuscitation.2020.07.022
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。